Nukkleus (NASDAQ:DFNS) Announces Earnings Results

Nukkleus (NASDAQ:DFNS) announced its quarterly earnings data on Wednesday. The company reported ($1.14) earnings per share for the quarter, Zacks reports.

Nukkleus Price Performance

Shares of DFNS stock traded up $0.00 during trading hours on Wednesday, reaching $0.37. The company had a trading volume of 1,753,673 shares, compared to its average volume of 2,209,703. The company has a market cap of $13.87 million, a price-to-earnings ratio of 0.02 and a beta of -5.98. Nukkleus has a 12 month low of $0.33 and a 12 month high of $26.21. The business has a fifty day simple moving average of $0.71 and a 200-day simple moving average of $2.84.

Hedge Funds Weigh In On Nukkleus

A number of hedge funds have recently bought and sold shares of DFNS. GM Advisory Group LLC purchased a new position in shares of Nukkleus during the 4th quarter valued at $56,000. BNP Paribas Financial Markets bought a new stake in Nukkleus in the 2nd quarter valued at about $56,000. Price T Rowe Associates Inc. MD purchased a new stake in Nukkleus during the fourth quarter valued at about $57,000. Millennium Management LLC bought a new position in Nukkleus during the fourth quarter worth about $60,000. Finally, State Street Corp boosted its position in Nukkleus by 70.7% during the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. 12.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on DFNS. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research note on Monday, March 23rd. Wall Street Zen downgraded shares of Nukkleus from a “hold” rating to a “sell” rating in a research report on Saturday, April 18th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.